Bills that would cover eye, dental and hearing examinations for US Medicare beneficiaries and at least partially provide for the costs of glasses, dental implants and hearing aids, were passed by the US House Ways and Means Committee on 22 October.
US House Panel Approves Medicare Hearing, Dental And Vision Coverage; Senate Bill Introduced
Three bills that would supply vision, dental and hearing coverage benefits – including eyeglasses, dental implants and hearing aids – to Medicare recipients was passed by the US House Ways and Means Committee on 22 October. The same troika of bills was approved by the House Energy and Commerce Committee last week, and two Senate committees with health-care jurisdiction are considering similar legislation.
More from Legislation
• By
Energy and Commerce Health Subcommittee Democrats focus on criticizing HHS Secretary Kennedy’s RIF announcement, including 3,500 FDA jobs among cuts across HHS agencies. Representatives were left wondering if user fee programs would continue, even if reauthorized.
AdvaMed’s top priorities for the 119th Congress include modernizing US Medicare services and expanding patients’ access to the latest medical technologies.
• By
A federal judge in Texas delivered what is most likely a fatal blow to the US FDA’s final rule, which would have regulated lab-developed tests as medical devices.
• By
President Trump’s CDC director nominee was pulled after vaccine positions appeared too extreme for some Republicans, but the nominations to lead the FDA and NIH advanced to the Senate floor despite last-minute drama.
More from Policy & Regulation
• By
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.
AdvaMed’s top priorities for the 119th Congress include modernizing US Medicare services and expanding patients’ access to the latest medical technologies.
• By
The Visby Medical Women’s Sexual Health Test is the first over-the-counter test cleared by the US Food and Drug Administration to detect chlamydia, gonorrhea and trichomoniasis. It delivers results in about 30 minutes.